ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,213Medicare Part D Prescriptions Filled, Including Refills

Rank: 45 out of 2456

$1.11M Total Retail Price of All Prescriptions

Rank: 30 out of 2456

682 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 682 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 682 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 15,987 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
AMLODIPINE BESYLATE 959 956 1 5
LIDODERM 607 607 2 58
LOVASTATIN 514 497 3 34
METOPROLOL SUCCINATE 509 507 4 13
OMEPRAZOLE 487 486 5 3
LISINOPRIL 478 473 6 1
SIMVASTATIN 383 378 7 2
METFORMIN HCL 380 362 8 11
LOSARTAN POTASSIUM 346 337 9 18
ALLOPURINOL 319 319 10 27
TRAZODONE HCL 311 309 11 17
ATENOLOL 300 290 12 6
FUROSEMIDE 267 267 13 8
LEVOTHYROXINE SODIUM 230 230 14 4
METOPROLOL TARTRATE 229 224 15 10
EVISTA 228 228 16 143
RANITIDINE HCL 221 220 17 31
TAMSULOSIN HCL 216 216 18 32
DOXAZOSIN MESYLATE 213 213 19 71
MELOXICAM 209 203 20 121
FLUOCINONIDE 188 184 21 302
FLUTICASONE PROPIONATE 188 186 21 30
WARFARIN SODIUM 188 188 21 9
HYDROCHLOROTHIAZIDE 188 176 21 7
GABAPENTIN 185 184 25 16
ATORVASTATIN CALCIUM 181 181 26 12
ALENDRONATE SODIUM 177 176 27 19
FENOFIBRATE 163 147 28 68
ZOLPIDEM TARTRATE 151 149 29 28
MIRTAZAPINE 135 135 30 29
DONEPEZIL HCL 132 132 31 23
PANTOPRAZOLE SODIUM 122 122 32 37
CLOBETASOL PROPIONATE 122 122 32 208
CARVEDILOL 110 110 34 54
GLIPIZIDE ER 109 109 35 89
TRIAMCINOLONE ACETONIDE 108 107 36 131
HYDROXYZINE HCL 107 107 R 37 177
ADVAIR DISKUS 107 107 37 36
TERAZOSIN HCL 105 105 39 76
ACETAMINOPHEN-CODEINE 100 100 S3 40 106
GLIPIZIDE 99 95 41 46
CLOTRIMAZOLE-BETAMETHASONE 99 99 41 182
DIOVAN 98 98 43 26
COMBIVENT 96 94 44 132
SPIRONOLACTONE 91 91 45 73
MECLIZINE HCL 90 90 46 107
CELEBREX 84 84 47 127
NIFEDIPINE ER 82 82 48 61
CYCLOBENZAPRINE HCL 81 81 R 49 77
NOVOLIN R 75 75 50 173
QUETIAPINE FUMARATE 74 74 51 47
PROAIR HFA 73 73 52 22
LANTUS 73 73 52 44
CITALOPRAM HBR 73 73 52 14
AMMONIUM LACTATE 73 73 52 265
ISOSORBIDE MONONITRATE ER 64 64 56 48
NAMENDA 63 63 57 42
COLCRYS 63 63 57 171
TRICOR 62 62 59 163
FINASTERIDE 62 62 59 66
GLYBURIDE 61 61 R 61 40
LOVAZA 61 61 61 219
BENICAR 60 55 63 160
HYDROCODONE-ACETAMINOPHEN 60 57 S3 63 20
NEXIUM 60 55 63 80
POTASSIUM CHLORIDE 57 57 66 33
METHIMAZOLE 56 56 67 248
CARBIDOPA-LEVODOPA 55 55 68 82
ACTOS 55 55 68 124
PREDNISONE 55 55 68 39
JANUVIA 53 53 71 81
CRESTOR 52 41 72 25
SERTRALINE HCL 51 51 73 21
RAMIPRIL 50 50 74 158
CLOPIDOGREL 50 50 74 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.